LobbyingRomark Global Pharma lobbying by quarter
Romark Global Pharma's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Pharmacy.
Romark Global Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $40K | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$120K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Brownstein Hyatt Farber Schreck | $120K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| GREGORY SUNSTRUM | Chief of Staff , Rep. Debbie Dingell; Deputy Chief of Staff and Leg. Director, Rep. Debbie Dingell ; Leg. Director, Rep. John Dingell; Leg. Assistant, Rep. John Dingell; Staff Assistant/Leg. Correspondent Rep. John Dingell | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/16for Q2 2024 | Brownstein Hyatt Farber Schreck | Under $5,000 |
| 24/04/17for Q1 2024 | Brownstein Hyatt Farber Schreck | Under $5,000 |
| 24/01/17for Q4 2023 | Brownstein Hyatt Farber Schreck | Under $5,000 |
| 23/10/17for Q3 2023 | Brownstein Hyatt Farber Schreck | Under $5,000 |
| 23/07/19for Q1 2023 | Brownstein Hyatt Farber Schreck | $60K |
| 23/07/19for Q2 2023 | Brownstein Hyatt Farber Schreck | $40K |
| 23/07/19for Q2 2023 | Brownstein Hyatt Farber Schreck | $60K |
| 23/04/18for Q1 2023 | Brownstein Hyatt Farber Schreck | $110K |
| 23/01/19for Q4 2022 | Brownstein Hyatt Farber Schreck | $20K |